Condition: TAVI(Transcatheter Aortic Valve Implantation) · Remote Monitoring · Arrythmia · Sponsor: Medical University of Silesia
The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.
This description comes directly from the study's public registry record.
Wojciech Wańha, MD, PhD · 504827636 · wojciech.wanha@gmail.com
Always discuss trial participation with your own doctor first.
| Division of Cardiology, Departement of Medical Science University of Turin, Città della Salute e Della Scienza | Turin, Italy | Recruiting |
| Department of Invasive Cardiology, Medical University of Białystok, Bialystok, Poland | Bialystok, Poland | Recruiting |
| Medical University of Silesia | Katowice, Poland | Recruiting |
| Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland | Katowice, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07521800